Multiple groups have reported the suppression of the in vitro NK cell-mediated cytotoxicity of several myeloma lines by antibodies blocking either DNAM-1 or NKG2D, and this effect was dependent upon ligand expression [21,23]. Here, CD226 is linked to plasma cell myeloma.